- Report
- June 2025
- 150 Pages
Global
From €3460EUR$3,850USD£3,035GBP
€4359EUR$4,850USD£3,823GBP
- Report
- June 2025
- 343 Pages
Global
From €4313EUR$4,799USD£3,783GBP
- Report
- October 2024
- 120 Pages
Global
From €5348EUR$5,950USD£4,690GBP
- Report
- February 2024
- 171 Pages
Global
From €4045EUR$4,500USD£3,547GBP
- Report
- November 2023
- 99 Pages
Global
From €3500EUR$4,171USD£3,177GBP
The ADME Studies market within the context of Diagnostics is a rapidly growing sector, focusing on the absorption, distribution, metabolism, and excretion of drugs and other substances in the body. This market is driven by the need for more accurate and reliable drug testing, as well as the increasing demand for personalized medicine. ADME studies are used to assess the safety and efficacy of drugs, as well as to identify potential drug interactions.
ADME studies are conducted by a variety of companies, including pharmaceutical companies, contract research organizations, and academic institutions. These companies provide services such as drug metabolism and pharmacokinetic studies, drug-drug interaction studies, and drug-food interaction studies. Additionally, they offer services such as bioanalytical testing, pharmacokinetic modeling, and drug safety assessment.
Some of the major companies in the ADME Studies market include Covance, PPD, Charles River Laboratories, Quintiles, and WuXi AppTec. Show Less Read more